Buy or sell Jasper Therapeutics stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Jasper Therapeutics Stock

Jasper Therapeutics is a biotechnology company focused on enabling safer conditioning and therapeutic



Notable Investors

Roche Venture Fund


Pure, LV

Total Funding


About Jasper Therapeutics Stock

Jasper is a biotechnology company focused on enabling safer conditioning agents to allow for expanded use of curative therapy with stem cell transplants and gene therapies. Jasper’s lead compound, JSP191, is in clinical development as a conditioning antibody that clears hematopoietic stem cells from bone marrow in patients undergoing a stem cell transplant.


Funding History

December 2019$35.0M
January 2020$0
January 2020$14.1M


Co-Founder & Vice President Operations & Program Management

Susan Prohaska

Co-Founder & Member Board of Directors

Judith Shizuru M.D.

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Jasper Therapeutics or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 260K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: